What is TTRX's EPS (diluted)?

TTRX (TTRX) reported EPS (diluted) of -$0.03 in Q1 2026.

How has TTRX's EPS (diluted) changed year-over-year?

TTRX's EPS (diluted) decreased by 200.0% year-over-year, from -$0.01 to -$0.03.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

TTRX TTRX EPS (Diluted)

EPS (Diluted) at other companies

Regeneron PharmaceuticalsREGN

$6.75-7.2%

Bausch Health CompaniesBHC

-$3.82-2,287%

Journey Medical CorporationDERM

-$0.08+55.6%

PTH

Pelthos Therapeutics Inc.PTHS

-$3.09+3.7%

Celldex TherapeuticsCLDX

-$1.18-45.7%

Arcutis Biotherapeutics, Inc.ARQT

-$0.09+55.0%

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's EPS (diluted)?: TTRX (TTRX) reported EPS (diluted) of -$0.03 in Q1 2026.
How has TTRX's EPS (diluted) changed year-over-year?: TTRX's EPS (diluted) decreased by 200.0% year-over-year, from -$0.01 to -$0.03.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.